182 related articles for article (PubMed ID: 26482423)
21. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877
[TBL] [Abstract][Full Text] [Related]
22. Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China.
Liu J; Song B; Fan T; Huang C; Xie C; Li J; Zhong W; Li S; Yu J
Asian Pac J Cancer Prev; 2011; 12(11):3055-61. PubMed ID: 22393989
[TBL] [Abstract][Full Text] [Related]
23. Malignant lymphoma in Eastern India: a retrospective analysis of 455 cases according to World Health Organisation classification.
Mondal SK; Mandal PK; Roy SD; Chattopadhyay S; Roy S; Biswas PK
J Cancer Res Ther; 2014; 10(2):354-8. PubMed ID: 25022391
[TBL] [Abstract][Full Text] [Related]
24. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
[TBL] [Abstract][Full Text] [Related]
25. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas.
Barrena S; Almeida J; Del Carmen García-Macias M; López A; Rasillo A; Sayagués JM; Rivas RA; Gutiérrez ML; Ciudad J; Flores T; Balanzategui A; Caballero MD; Orfao A
Histopathology; 2011 May; 58(6):906-18. PubMed ID: 21438908
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
28. Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.
Pulte D; Jansen L; Gondos A; Emrich K; Holleczek B; Katalinic A; Brenner H;
Leuk Lymphoma; 2013 May; 54(5):979-85. PubMed ID: 23098058
[TBL] [Abstract][Full Text] [Related]
29. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
[TBL] [Abstract][Full Text] [Related]
32. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BC; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):1-14. PubMed ID: 25174022
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Profile of Hodgkin and Non-Hodgkin Lymphoma.
Shahid R; Gulzar R; Avesi L; Hassan S; Danish F; Mirza T
J Coll Physicians Surg Pak; 2016 Feb; 26(2):103-7. PubMed ID: 26876395
[TBL] [Abstract][Full Text] [Related]
34. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
35. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Ann Hematol; 2016 Jan; 95(2):245-51. PubMed ID: 26537613
[TBL] [Abstract][Full Text] [Related]
36. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
Krivolapov IuA
Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
[TBL] [Abstract][Full Text] [Related]
37. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
38. Small B cell Non-Hodgkins Lymphoma in Pakistan.
Aftab K; Bhurgri Y; Pervez S
J Pak Med Assoc; 2006 Jan; 56(1):22-5. PubMed ID: 16454131
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
40. Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis.
Ye X; Mneina A; Johnston JB; Mahmud SM
Hematol Oncol; 2017 Jun; 35(2):206-214. PubMed ID: 26482323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
